Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Correlation Between Clinical Outcome and Disease Kinetics by Quantitative PCR in Myeloma Patients Following Post-Transplant Consolidation with Bortezomib, Thalidomide and Dexamethasone.

Blood (2009) 114 (22): 960.

https://doi.org/10.1182/blood.V114.22.960.960

Published: 2009

Journal Articles

Characteristics of the Immunoglobulin Heavy Chain (IgH) Rearrangement in Multiple Myeloma (MM): An Analysis On 308 Cases.

Blood (2009) 114 (22): 2808.

https://doi.org/10.1182/blood.V114.22.2808.2808

Published: 2009

Journal Articles

Major Shrinking of Residual Tumor Cell Burden and Achievement of Molecular Remissions in Myeloma Patients Undergoing Post-Trasplant Consolidation with Bortezomib, Thalidomide and Dexamethasone: A Qualitative and Quantitative PCR Study

Marco Ladetto, MD, Gloria Pagliano, PhD, Simone Ferrero, MD, Federica Cavallo, MD, Daniela Drandi, PhD, Michela Boi, PhD, Loredana Santo, MD, Patrizia Pregno, MD, Mariella Grasso, MD, Anna Marina Liberati, MD, Tommaso Caravita, MD, Francesco Pisani, MD, Claudia Crippa, MD, Vincenzo Callea, MD, Antonietta Falcone, MD, Sergio Morandi, MD, Mario Boccadoro, MD, Antonio Palumbo, MD

Blood (2008) 112 (11): 3683.

https://doi.org/10.1182/blood.V112.11.3683.3683

Published: 2008

Journal Articles

Consolidation with Bortezomib, Thalidomide and Dexamethasone Induces Molecular Remissions in Autografted Multiple Myeloma Patients.

Marco Ladetto, Gloria Pagliano, Ilaria Avonto, Loredana Santo, Simone Ferrero, Federica Cavallo, Monica Astolfi, Patrizia Pregno, Claudia Crippa, Anna Marina Liberati, Vincenzo Callea, Luca De Rosa, Antonietta Falcone, Mariella Grasso, Daniela Drandi, Mario Boccadoro, Antonio Palumbo

Blood (2007) 110 (11): 530.

https://doi.org/10.1182/blood.V110.11.530.530

Published: 2007

Journal Articles

Impact of Early Consolidation with Bortezomib, Thalidomide and Dexamethasone on Molecularly-Detectable Disease in MM Patients in CR or VGPR Following Autologous Transplantation: Uncommon Achievement of Molecular Remission Despite Evidence of Tumor Load Reduction by Real Time PCR.

Marco Ladetto, Monica Astolfi, Loredana Santo, Ilaria Avonto, Federica Cavallo, Gloria Pagliano, Patrizia Pregno, Mariella Grasso, Anna Marina Liberati, Tommaso Caravita, Francesco Pisani, Tommasina Guglielmelli, Elisa Genuardi, Rossana Crivelli, Carmen Cristiano, Daniela Drandi, Mario Boccadoro, Antonio Palumbo

Blood (2006) 108 (11): 3100.

https://doi.org/10.1182/blood.V108.11.3100.3100

Published: 2006

Journal Articles

Array-Based Comparative Genomic Hybridization (Array-CGH) in Multiple Myeloma (MM) and Plasma Cell Leukemia (PCL): Recurrent Imbalances within a Highly Heterogeneous Background of Genomic Disruption.

Daniela Drandi, Marco Ladetto, Sonia Vallet, Loredana Santo, Irene Ricca, Maria Dell’Aquila, Luigia Monitillo, Monica Astolfi, Marina Ruggeri, Maria Teresa Ambrosini, Federica De Marco, Lydia Marino, Barbara Mantoan, Gloria Pagliano, Paola Omedè, Antonio Palumbo, Mario Boccadoro.

Blood (2005) 106 (11): 5088.

https://doi.org/10.1182/blood.V106.11.5088.5088

Published: 2005

Journal Articles

Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome

Blood (2005) 105 (12): 4784–4791.

https://doi.org/10.1182/blood-2004-11-4201

Published: 2005

Journal Articles

Long-Term Monitoring of Cancer-Free Subjects Carrying Non-Lymphoma Associated bcl2/IgH Rearrangements (NLABR): Prolonged Persistence of Clonal Populations Potentially Related to Follicular Lymphoma (FL).

Marco Ladetto, MD, Barbara Mantoan, PhD, Federica De Marco, MD, Berardino Pollio, MD, Daniela Drandi, PhD, Irene Ricca, MD, Sonia Vallet, MD, Mara Compagno, PhD, Monica Astolfi, PhD, Maria Dell’Aquila, PhD, Roberto Francese, PhD, Gloria Pagliano, PhD, Luigia Monitillo, PhD, Giacomo Tamponi, MD, Mario Boccadoro, MD, Corrado Tarella, MD

Blood (2004) 104 (11): 1373.

https://doi.org/10.1182/blood.V104.11.1373.1373

Published: 2004

Journal Articles

Cyclooxygenase-2 (COX-2) Is Frequently Expressed in Multiple Myeloma (MM) and Is Associated with Poor Outcome.

Marco Ladetto, Sonia Vallet, Andreas Trojan, Maria Dell’Aquila, Luigia Monitillo, Loredana Santo, Alessandra Bertola, Patrizia Falco, Federica Cavallo, Daniela Drandi, Irene Ricca, Gloria Pagliano, Monica Astolfi, Alberto Rocci, Beata Bode, Antonio Palumbo, Corrado Tarella, Paola Omedé, Mario Boccadoro

Blood (2004) 104 (11): 2450.

https://doi.org/10.1182/blood.V104.11.2450.2450

Published: 2004

Journal Articles

Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders

Marco Ladetto, Mara Compagno, Irene Ricca, Marco Pagano, Alberto Rocci, Monica Astolfi, Daniela Drandi, Paola Francia di Celle, Maria Dell'Aquila, Barbara Mantoan, Sonia Vallet, Gloria Pagliano, Federica De Marco, Roberto Francese, Loredana Santo, Alessandra Cuttica, Carlo Marinone, Mario Boccadoro, Corrado Tarella

Blood (2004) 103 (12): 4644–4649.

https://doi.org/10.1182/blood-2003-12-4412

Published: 2004

NARROW

Correlation Between Clinical Outcome and Disease Kinetics by Quantitative PCR in Myeloma Patients Following Post-Transplant Consolidation with Bortezomib, Thalidomide and Dexamethasone.

Characteristics of the Immunoglobulin Heavy Chain (IgH) Rearrangement in Multiple Myeloma (MM): An Analysis On 308 Cases.

Major Shrinking of Residual Tumor Cell Burden and Achievement of Molecular Remissions in Myeloma Patients Undergoing Post-Trasplant Consolidation with Bortezomib, Thalidomide and Dexamethasone: A Qualitative and Quantitative PCR Study

Consolidation with Bortezomib, Thalidomide and Dexamethasone Induces Molecular Remissions in Autografted Multiple Myeloma Patients.

Impact of Early Consolidation with Bortezomib, Thalidomide and Dexamethasone on Molecularly-Detectable Disease in MM Patients in CR or VGPR Following Autologous Transplantation: Uncommon Achievement of Molecular Remission Despite Evidence of Tumor Load Reduction by Real Time PCR.

Array-Based Comparative Genomic Hybridization (Array-CGH) in Multiple Myeloma (MM) and Plasma Cell Leukemia (PCL): Recurrent Imbalances within a Highly Heterogeneous Background of Genomic Disruption.

Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome

Long-Term Monitoring of Cancer-Free Subjects Carrying Non-Lymphoma Associated bcl2/IgH Rearrangements (NLABR): Prolonged Persistence of Clonal Populations Potentially Related to Follicular Lymphoma (FL).

Cyclooxygenase-2 (COX-2) Is Frequently Expressed in Multiple Myeloma (MM) and Is Associated with Poor Outcome.

Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only